CRASH-3 Publications

Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial

The CRASH-3 trial collaborators

The Lancet

Want to hear from us?

Sign up to our trial newsletters and get the latest information on our trials.
Learn More
Menu